APAL MW Partners with Sitetracker to Accelerate Renewable Energy Projects Across France
15.7.2025 15:00:00 CEST | Business Wire | Press Release
Sitetracker, the global leader in complete Asset Lifecycle Management (ALM) software, today announced a strategic partnership with APAL MW, an independent power producer (IPP) specializing in solar photovoltaic, wind energy development and battery energy storage system (BESS) in France. This collaboration will enable APAL MW to significantly improve operational efficiency, foster stronger team collaboration, and gain real-time visibility across its growing portfolio of renewable energy projects.
Empowering APAL MW’s Growth as a Modern IPP
APAL MW, operating on a robust IPP model, selected Sitetracker following a detailed evaluation of the platform’s capabilities to support complex renewable project development. The partnership is a key component of APAL MW’s strategy to streamline the entire project lifecycle—from site identification and permitting to construction and long-term operation—ensuring timely, cost-effective delivery of clean energy infrastructure.
Key benefits expected from the partnership include:
- Optimized Efficiency: Sitetracker will automate critical workflows, minimize manual data handling, and standardize project processes, driving significant gains in productivity and consistency.
- Improved Collaboration: A single source of truth for project data will enable tighter coordination across internal teams, contractors, and financial partners like SUSI Partners.
- Greater Control and Insight: APAL MW will gain comprehensive, real-time dashboards covering project status, budget adherence, and potential risks, enabling faster, better-informed decisions.
“APAL MW represents the next generation of forward-thinking renewable energy providers,” said Giuseppe Incitti, CEO of Sitetracker. “We’re proud to support their mission with a platform purpose-built to manage the scale, speed, and complexity of modern energy infrastructure. This partnership is a strong example of how Sitetracker helps companies move faster—speeding up project completion, minimizing delays, and ensuring agility in the face of shifting economic and regulatory landscapes.”
Sitetracker: A Strategic Fit for Scaling Renewable Energy
APAL MW’s innovation-driven approach focuses on accelerating France’s energy transition through precision project execution and strong financial partnerships. Sitetracker’s ALM platform aligns with this vision by equipping APAL MW with tools to manage the complexity and scale of large renewable deployments.
Platform features central to this collaboration include advanced mapping tools for site selection, automated compliance workflows, and detailed reporting dashboards for both development and operational stages. This ensures APAL MW can effectively manage assets across the full lifecycle.
“Our mission at APAL MW is to be a driving force in France’s energy transition, developing high-quality renewable energy assets efficiently,” said A. Leclerc & A. Pedersoli, co-founders of APAL MW. “Partnering with Sitetracker is a crucial step in achieving this. Their platform provides the comprehensive control and visibility we need to optimize every stage of our projects, from initial concept to long-term operation. This partnership will undoubtedly enhance our ability to deliver sustainable energy solutions faster and more reliably.”
A Shared Commitment to the Energy Transition
This strategic alliance is expected to yield faster project cycles, reduced administrative overhead, and more predictable delivery outcomes—key enablers for APAL MW’s expansion as a premier renewable energy player in France. Together, Sitetracker and APAL MW are well-positioned to make a meaningful contribution to national decarbonization targets.
About Sitetracker
Sitetracker empowers owners, operators, contractors, and other stakeholders to streamline and optimize the end-to-end asset lifecycle of critical infrastructure. As the leading global complete Asset Lifecycle Management platform, Sitetracker helps innovative companies like Vodafone, Ericsson, ENGIE, Telefonica, Cypress Creek Renewables, Cox, Iberdrola, EVgo, Vantage Towers, Southern Company, Zayo, Tilson, Nextera, EDOTCO, E.On, Axione, and TEP efficiently plan, build, operate, and maintain millions of projects, sites, and assets. Sitetracker delivers operational excellence and creates full transparency across industries such as digital infrastructure, renewables, EV charging, utilities, and real estate by driving safe, efficient teams, ensuring healthy projects, and enabling organizations to manage scale, growth, and complexity. Trusted by hundreds of industry leaders, Sitetracker advances a more connected and sustainable future across the world. Manage What’s Critical, with Sitetracker.
For more information, please request a demo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250715375048/en/
Contacts
Media Contact
Kathleen Ojo
Sitetracker
press@sitetracker.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom